Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Investigative Dermatology

• Publication date

  1996-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1523-1747.EP12330869PMID 8941670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients.

  1996cited by this paper
• Th1 and Th2 subsets: paradigms lost?

  1995cited by this paper
• Mutations in the Laminin 5 LAMB3 Gene in Generalized Atrophic Benign Epidermolysis Bullosa

  1995cited by this paper
• IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.

  1995cited by this paper
• Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions.

  1995cited by this paper
• Th2 cytokine profile in cutaneous T-cell lymphoma.

  1995cited by this paper
• Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro.

  1995cited by this paper
• New perspectives in experimental and clinical research for cutaneous T cell lymphomas.

  1995cited by this paper
• Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?

  1995cited by this paper
• Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression

  1994cited by this paper
• Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.

  1994cited by this paper
• The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor‐infiltrating lymphocytes

  1994cited by this paper
• Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.

  1994cited by this paper
• T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells

  1994cited by this paper
• T cells involved in psoriasis vulgaris belong to the Th1 subset.

  1994cited by this paper
• A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats.

  1994cited by this paper
• Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.

  1994cited by this paper
• Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments.

  1994cited by this paper
• Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes.

  1994cited by this paper
• The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

  1993cited by this paper
• Cytokines in malignant lymphomas: review and prospective evaluation.

  1993cited by this paper
• Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expression

  1993cited by this paper
• The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.

  1993cited by this paper
• Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice.

  1993cited by this paper
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

  1993cited by this paper
• Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.

  1993cited by this paper
• Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.

  1992cited by this paper
• Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.

  1992cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

  1991cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Skin exudate levels of interleukin 6, interleukin i and other cytokines in mycosis fungoides

  1990cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Risk of second malignancy after cutaneous T‐cell lymphoma

  1989cited by this paper
• Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper
• Mycosis fungoides.

  1985cited by this paper
• Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.

  1980cited by this paper

• Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.

  2025cites this paper
• Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma

  2025cites this paper
• Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sézary Syndrome Compared to a Matched Control Cohort

  2023cites this paper
• Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome

  2022cites this paper
• Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab

  2022influential citation
• Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.

  2021cites this paper
• Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma

  2021cites this paper
• Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas

  2021cites this paper
• Normal and Cancer Fibroblasts Differentially Regulate Cytokine Genes and TWIST1 and TOX  Expression in Cutaneous T-cell Lymphoma 

  2020cites this paper
• High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies

  2020cites this paper
• Special Considerations in the Treatment of Mycosis Fungoides

  2019cites this paper
• Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments

  2019cites this paper
• Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma

  2019cites this paper
• Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile

  2018cites this paper
• Cutaneous T-Cell Lymphoma

  2018cites this paper
• Interleukin‐25 is involved in cutaneous T‐cell lymphoma progression by establishing a T helper 2‐dominant microenvironment

  2018cites this paper
• Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma

  2018cites this paper
• Amendment history : Corrigendum ( March 2007 ) Immunopathogenesis and therapy of cutaneous T cell lymphoma

  2018cites this paper
• IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model

  2018cites this paper
• Modern concepts of the mycosis fungoides pathogenesis

  2018cites this paper
• New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma

  2018cites this paper
• Untersuchungen zur Analytik und diagnostischen Aussagekraft von IL-10 und TNF-α beim Hund

  2017cites this paper
• IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression

  2017cites this paper
• Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.

  2017cites this paper
• Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma.

  2016cites this paper
• Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review

  2016cites this paper
• Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

  2016cites this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses

  2016cites this paper
• Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets

  2016cites this paper
• Erratum to: Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review

  2016cites this paper
• Mac attack: macrophages as key drivers of cutaneous T‐cell lymphoma pathogenesis

  2016cites this paper
• New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome

  2015cites this paper
• Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.

  2015cites this paper
• The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

  2015cites this paper
• Positividade do imunomarcador FOXP3 em células T reguladoras em lesões de micose fungoide em fases clínicas iniciais e em dermatoses inflamatórias como fator auxiliar para o diagnóstico diferencial

  2015cites this paper
• Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma.

  2015cites this paper
• Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.

  2014cites this paper
• Skin Barrier Dysfunction and Low Antimicrobial Peptide Expression in Cutaneous T-cell Lymphoma

  2014cites this paper
• Möglichkeiten und Grenzen der klonspezifischen, quantitativen Real-Time-PCR bei Patienten mit Sézary Syndrom

  2014cites this paper
• Immunological milieu in mycosis fungoides and Sézary syndrome

  2014cites this paper
• The role of IL-32 in cutaneous T-cell lymphoma.

  2014cites this paper
• Biology of Human Tumors Skin Barrier Dysfunction and Low Antimicrobial Peptide Expression in Cutaneous T-cell Lymphoma

  2014cites this paper
• dysregulation Staphylococcal enterotoxins stimulate lymphoma-associated immune

  2014influential citation
• Receptors, cells and circuits involved in pruritus of systemic disorders.

  2014cites this paper
• Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.

  2014influential citation
• Serum visfatin levels in patients with atopic dermatitis and cutaneous T-cell lymphoma.

  2013cites this paper
• Role of IL-10 in the Trimellitic Anhydride-induced Contact Dermatitis

  2013cites this paper
• The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T‐cell lymphoma patients

  2012cites this paper
• Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies

  2012cites this paper
• Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.

  2012cites this paper
• Interleukin‐17 expression in neutrophils and Th17 cells in cutaneous T‐cell lymphoma associated with neutrophilic infiltrate of the skin

  2012cites this paper
• Molecular aspects of cutaneous T-cell lymphoma : genetic alterations underlying clinical behavior

  2012cites this paper
• A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.

  2012cites this paper
• Current and emerging therapeutics for cutaneous T-Cell lymphoma: Histone deacetylase inhibitors

  2012cites this paper
• Frontal fibrosing alopecia in a patient with common variable immunodeficiency

  2012cites this paper
• Pathogenesis of Mycosis fungoides

  2011cites this paper
• Pathogenese der Mycosis fungoides

  2011cites this paper
• Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

  2011cites this paper
• Linfoma cutáneo de células T. Revisión del tema con énfasis en la inmunopatogénesis

  2011cites this paper
• The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL‐10 expression in cutaneous T‐cell lymphoma cells

  2011cites this paper
• Evolving Insights in the Pathogenesis and Therapy of Cutaneous T‐cell lymphoma (Mycosis Fungoides and Sezary Syndrome)

  2011cites this paper
• Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.

  2011cites this paper
• Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma

  2010cites this paper
• [Cutaneous lymphoma].

  2009cites this paper
• Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation.

  2009cites this paper
• Опыт лечения грибовидного микоза и синдрома Сезари в зависимости от стадий заболевания. Результаты собственных исследований и обзор литературы

  2009cites this paper
• Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.

  2009cites this paper
• Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium‐based compound, AS101

  2008cites this paper
• Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides

  2008cites this paper
• Interleukin‐10 gene polymorphism influences the prognosis of T‐cell non‐Hodgkin lymphomas

  2007influential citation
• General Principles of Tumor Immunotherapy

  2007cites this paper
• Immunomodulatory Molecules of the Immune System

  2007cites this paper
• Long‐term interleukin‐10 presence induces the development of a novel, monocyte‐derived cell type

  2007cites this paper
• Kutane maligne Lymphome: Update 2006 zu ausgewählten Aspekten

  2006cites this paper
• Cutaneous manifestations of Hodgkin's disease

  2006cites this paper
• Cutaneous malignant lymphomas: Update 2006

  2006cites this paper
• A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.

  2006cites this paper
• Cytokine gene polymorphisms in patch-stage mycosis fungoides.

  2005cites this paper
• Immunopathogenesis and therapy of cutaneous T cell lymphoma.

  2005cites this paper
• Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.

  2005cites this paper
• Thérapeutiques immunomodulatrices innovantes en cours d’évaluation

  2005cites this paper
• Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells.

  2005cites this paper
• Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.

  2005cites this paper
• Cutaneous T-cell lymphoma : molecular pathogenesis and clinical behaviour

  2005cites this paper
• [New immunomodulating treatments in evaluation for cutaneous T-cell lymphomas].

  2005cites this paper
• PUVA and Interferon-γ Combination Therapy for Plaque Stage Mycosis Fungoides

  2004cites this paper
• Cutaneous T-cell lymphoma : malignant proliferation of T-regulatory cells

  2004cites this paper
• Tumors of Skin-Homing Lymphocytes

  2004cites this paper
• The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.

  2004cites this paper
• Cytokine gene polymorphisms in patch-stage mycosis fungoides1

  2004cites this paper
• Early up‐regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

  2004cites this paper
• Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

  2004cites this paper
• Cutaneous T-cell lymphoma.

  2004cites this paper
• Zytokine und kutane Lymphome

  2004cites this paper
• Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.

  2003cites this paper
• Cytokine and anticytokine therapy in dermatology

  2003cites this paper
• The use of cytokines, fusion proteins and antibodies to treat cutaneous T‐cell lymphoma

  2003cites this paper
• Factores clínicos y analíticos de progresión y supervivencia en linfomas cutáneos de células T (micosis fungoide/síndrome de Sézary)

  2003cites this paper
• Current Status of Cutaneous T-Cell Lymphoma: Molecular Diagnosis, Pathogenesis, Therapy and Future Directions

  2003cites this paper
• Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell‐based immunotherapy

  2003cites this paper